SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-19-143149
Filing Date
2019-05-09
Accepted
2019-05-09 17:11:12
Documents
4
Effectiveness Date
2019-05-09

Document Format Files

Seq Description Document Type Size
1 S-8 d710540ds8.htm S-8 57133
2 EX-5.1 d710540dex51.htm EX-5.1 8853
3 EX-23.1 d710540dex231.htm EX-23.1 1701
4 GRAPHIC g710540g72g10.gif GRAPHIC 1277
  Complete submission text file 0001193125-19-143149.txt   70599
Mailing Address 111 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 111 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 415-365-5600
FIVE PRIME THERAPEUTICS INC (Filer) CIK: 0001175505 (see all company filings)

IRS No.: 260038620 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-231341 | Film No.: 19811715
SIC: 2834 Pharmaceutical Preparations